NS Healthcare is using cookies
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
Respiratory and gastrointestinal infections are among the top 10 causes of death in the world and have remained one of the leading causes of death globally in the past 15 years.
SECTOR: Patient Care
SUB SECTOR: Imaging, Diagnostics and Analysis
SPECIALITY: Imaging, Diagnostics and Analysis
Respiratory and gastrointestinal infections are among the top 10 causes of death in the world and have remained one of the leading causes of death globally in the past 15 years.
Respiratory infections caused three million deaths worldwide in 2016. The number of deaths from diarrhoeal diseases was 1.4 million in 2016. Similarly, tuberculosis is still among the top 10 causes of death, with a death toll of 1.3 million.
Identifying the pathogens causing the infections is one of the most important means for treatment and for the reduction of preventable deaths. Additionally, it enables a country’s health system to be assessed and the focus of its public health actions to be determined.
Molecular techniques such as Real Time PCR are high-sensitivity and specificity techniques that enable identification of the etiological agent in a short period of time. The VIASURE Real Time PCR kit is in a lyophilised format that is ready for use. Its high stability and resistance to high temperatures allows transport and storage at room temperature for a long time, avoiding the use of a network set-up and ensuring the maintenance of the cold chain, as well as high reproducibility of the results due to the absence of extra pipetting.
VIASURE Real Time PCR kits are designed to detect multiple pathogens in a single sample, depending on the area and public health situation. Their high portfolio of products and flexibility of use allow the kits to be adapted for the diagnosis of different infectious diseases, helping to monitor the effectiveness of the therapeutic treatment and assisting in clinical decision-making.
Certest Biotec S.L.
Polígono Industrial Río Gállego II Calle J, Nº1
50840, San Mateo de Gállego
Zaragoza
Spain
URL: https://www.certest.es/
CerTest Biotec is dedicated to the identification of infection-causing pathogens, and has embraced molecular techniques to efficiently and accurately detect multiple pathogens in a single sample.
Download White PaperBased in Zaragoza, Spain, CerTest Biotec is an independent biotechnology company devoted to the development and manufacturing of IVD diagnostic products in the human clinical field.
Download White PaperWith the fight against antibiotic resistance increasing, so is the importance of a more sensitive and faster diagnosis to offer a personalised treatment. CerTest has responded to that by developing a range of multiplex reactions for the detection and differentiation of multiple genes, which confer resistance to antibiotics – chiefly, through its Viasure products.
Download White PaperCerTest Biotec offers exceptional diagnostic abilities in a flexible and all-encompassing solution, accompanied by a user-friendly interface that offers cross communication with PCR systems. It does so through the automation of reliable molecular testing.
Download White PaperCertest, a company specialized in the development, manufacturing, and commercialization of solutions for the diagnosis of infectious diseases, is preparing to participate in the annual AACC exhibition, recognized as one of the largest global gatherings for the diagnostics sector. This year, the event will take place in Anaheim, California, on July 25th, 26th, and 27th.
The VIASURE Real Time PCR product portfolio for the diagnosis of infectious diseases in human samples is now expanded with 14 new products for the following families: